Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-087534

EVP, Chief Financial Officer acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Duarte Ira EVP, Chief Financial Officer 2025-06-16 Option exercise +12,500 148,649 D
Derivatives
Duarte Ira EVP, Chief Financial Officer 2025-06-16 Option exercise · Restricted Stock Units +12,500 25,000 D
Loading xslF345X05/ownership.xml…